1. Home
  2. HALO vs BZ Comparison

HALO vs BZ Comparison

Compare HALO & BZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$98.66

Market Cap

11.2B

Sector

Health Care

ML Signal

N/A

BZ

KANZHUN LIMITED American Depository Shares

HOLD

Current Price

$15.51

Market Cap

6.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HALO
BZ
Founded
1998
2013
Country
United States
China
Employees
423
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
11.2B
6.1B
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
HALO
BZ
Price
$98.66
$15.51
Analyst Decision
Buy
Strong Buy
Analyst Count
11
3
Target Price
$78.64
$23.00
AVG Volume (30 Days)
2.2M
3.1M
Earning Date
05-05-2026
05-21-2026
Dividend Yield
N/A
1.24%
EPS Growth
N/A
N/A
EPS
3.11
N/A
Revenue
$151,862,000.00
N/A
Revenue This Year
$28.24
$15.92
Revenue Next Year
$12.56
$12.78
P/E Ratio
$32.36
$22.61
Revenue Growth
N/A
N/A
52 Week Low
$61.23
$12.56
52 Week High
$104.78
$25.26

Technical Indicators

Market Signals
Indicator
HALO
BZ
Relative Strength Index (RSI) 73.74 48.36
Support Level $67.12 $12.95
Resistance Level N/A $21.60
Average True Range (ATR) 3.12 0.58
MACD 1.42 -0.15
Stochastic Oscillator 73.42 24.39

Price Performance

Historical Comparison
HALO
BZ

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About BZ KANZHUN LIMITED American Depository Shares

Kanzhun's Boss Zhipin job platform connects job seekers and employers. Boss Zhipin is China's largest online recruitment platform based on monthly active users, or MAU, and was established in 2014. Kanzhun earns revenue by providing services to enterprise customers primarily through its mobile app, which promotes engagement between recruiters and workers and operates on a recommendation basis powered by artificial intelligence. The platform specializes in transportation, logistics, construction, and service-based industries. About 85% of the companies looking to hire are small and medium-size enterprises. Its main competitors are 58.com, 51job, and Zhilian Zhaopin. Tencent has a 9.2% stake in Kanzhun.

Share on Social Networks: